• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Retractable Technologies

Retractable Technologies declares dividends

July 1, 2022 By Sean Whooley

Retractable Technologies

Retractable Technologies (NYSE:RVP) announced that its board of directors declared dividends to holders of its convertible preferred stock. The dividends declared to holders of Retractable Technologies’ Series II Class B and Series III Class B convertible preferred stock totals amounts of $39,050 and $19,061.25, respectively. Dividends have accrued a $1 per share per annum and […]

Filed Under: Business/Financial News, Drug-Device Combinations, Wall Street Beat Tagged With: Retractable Technologies

Retractable Technologies downsizes workforce

June 8, 2022 By Danielle Kirsh

Retractable Technologies

Retractable Technologies this week announced that it has reduced its workforce by 16% due to the completion of its facility expansion efforts — and the completion of U.S. government orders related to COVID-19 vaccines. The staff reduction will affect the Little Elm, Texas-based company’s production, operations and logistics departments. Retractable Technologies said in an SEC filing that there […]

Filed Under: Pharmaceuticals Tagged With: Retractable Technologies

Retractable Technologies wins $27M federal contract

May 25, 2021 By Nancy Crotti

RTI-NEW-Logo-Retractable-Technologies

Retractable Technologies (NYSE:RVP) announced that it has received a government contract worth more than $27.3 million for its syringes. The new contract is the third multi-million-dollar deal that the U.S. Department of Health & Human Services (HHS) has awarded to the Little Elm, Texas-based company since February 2020. The company landed an $83.8 million contract with […]

Filed Under: Business/Financial News, Featured Tagged With: Retractable Technologies, U.S. Department of Health & Human Services

Retractable Technologies lands $54.2M federal contract for syringes

February 17, 2021 By Sean Whooley

RTI-NEW-Logo-Retractable-Technologies

Retractable Technologies (NYSE:RVP) announced that it received a government contract worth more than $54.2 million for its syringes. Little Elm, Texas-based Retractable Technologies’ contract and purchase order was made by the U.S. Health & Human Services Dept. (HHS) with a base price of $54,217,800 for a five-month period between Feb. 15, 2021, and July 14, 2021. […]

Filed Under: Business/Financial News, Contract Services, Drug-Device Combinations, Featured Tagged With: HHS, Retractable Technologies, syringes

Report: Global syringes market set to reach $32.4B by 2027

February 12, 2021 By Sean Whooley

Market research released this week suggests that the global syringes market will reach $32.39 billion by 2027. Allied Market Research published a report estimating the global syringes market sat at $15.34 billion in 2019, with expectations of hitting $32.39 billion in value by 2027, with a compound annual growth rate (CAGR) of 9.6% from 2020 […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: bbraun, Becton Dickinson, Cardinal Health, Medline Industries, Retractable Technologies, syringes, Terumo Corp.

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS